CRM
Cramer Rosenthal McGlynn’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-52,659
| Closed | -$1.71M | – | 223 |
|
|
2016
Q4 | $1.71M | Sell |
52,659
-1,148,205
| -96% | -$37.3M | 0.03% | 173 |
|
|
2016
Q3 | $40.7M | Sell |
1,200,864
-558,665
| -32% | -$18.9M | 0.62% | 73 |
|
|
2016
Q2 | $62M | Buy |
1,759,529
+339,415
| +24% | +$12M | 1% | 25 |
|
|
2016
Q1 | $42.1M | Buy |
1,420,114
+148,420
| +12% | +$4.4M | 0.66% | 68 |
|
|
2015
Q4 | $41.1M | Sell |
1,271,694
-215,965
| -15% | -$6.97M | 0.62% | 71 |
|
|
2015
Q3 | $46.7M | Sell |
1,487,659
-199,140
| -12% | -$6.25M | 0.63% | 62 |
|
|
2015
Q2 | $56.6M | Sell |
1,686,799
-284,620
| -14% | -$9.54M | 0.7% | 54 |
|
|
2015
Q1 | $68.6M | Sell |
1,971,419
-228,840
| -10% | -$7.96M | 0.77% | 38 |
|
|
2014
Q4 | $68.5M | Sell |
2,200,259
-987,831
| -31% | -$30.8M | 0.7% | 56 |
|
|
2014
Q3 | $94.3M | Sell |
3,188,090
-531,347
| -14% | -$15.7M | 0.94% | 36 |
|
|
2014
Q2 | $110M | Buy |
3,719,437
+269,479
| +8% | +$8M | 0.89% | 34 |
|
|
2014
Q1 | $111M | Sell |
3,449,958
-360,268
| -9% | -$11.6M | 0.85% | 33 |
|
|
2013
Q4 | $117M | Sell |
3,810,226
-231,527
| -6% | -$7.09M | 0.83% | 39 |
|
|
2013
Q3 | $116M | Sell |
4,041,753
-90,930
| -2% | -$2.61M | 0.87% | 41 |
|
|
2013
Q2 | $116M | Buy |
+4,132,683
| New | +$116M | 0.87% | 36 |
|